DuPont to acquire membrane business from Evoqua Water Technologies Corp.

DuPont to acquire membrane business from Evoqua Water Technologies Corp.
Published: 20 October 2019 - 9:45 a.m.

DuPont announced it has signed an agreement to acquire the Memcor business including ultrafiltration and membrane biofiltration technologies from Evoqua Water Technologies Corp.

The transaction is expected to close by the end of 2019, subject to customary closing conditions and regulatory approvals.

“Our strategic intent for the Water Solutions business is to have a robust portfolio of technologies so that our talented global organization can leverage a broad range of solutions to solve our customers’ most pressing challenges,” said Marc Doyle, DuPont chief executive officer. “Recently, we announced the intended acquisition of BASF’s ultrafiltration membrane business. This second announcement reinforces our commitment to invest in specialty solutions aligned with high growth, attractive end markets where our continued innovation and customer relationships add value.”

The Evoqua ultrafiltration and membrane biofiltration (MBR) technologies add to DuPont’s leading portfolio of water purification and separation capabilities including ultrafiltration, reverse osmosis and ion exchange resins. Together with the intended acquisition of BASF’s ultrafiltration business, which is also expected to close by the end of 2019 subject to customary closing conditions and regulatory approvals, DuPont will be even better positioned to provide the products, technology and geographic diversification needed to meet current and future customer demand.

“DuPont and Evoqua have enjoyed a mutually beneficial long-standing business relationship, and this transaction further complements both companies’ strengths to focus more effectively on what each does best,” said HP Nanda, Global Vice President & General Manager, DuPont Water Solutions. “The addition of Evoqua’s ultrafiltration portfolio opens DuPont Water Solutions to additional market spaces including membrane bioreactors, submerged and pressurized ultrafiltration systems bringing more choice and opportunity for customers.”

“This transaction is an excellent opportunity for Memcor and its employees to align with DuPont’s strength in membrane development and material science,” said Ron Keating, CEO of Evoqua. “Evoqua’s strategy is to source components that we can incorporate into innovative products, and integrated solutions and services, that align with our strengths. We are confident that the Memcor product line will thrive under DuPont’s leadership and we look forward to continuing our decades long relationship with DuPont to bring integrated membrane-based systems and solutions to the marketplace.”


Click here to add your comment

Please add your comment below
Name
Country
Email
Your email address will not be published
Captcha